Open Access. Powered by Scholars. Published by Universities.®

Engineering Commons™

Open Access. Powered by Scholars. Published by Universities.®

Biomedical Engineering and Bioengineering

Institution
Keyword
Publication Year
Publication
Publication Type
File Type

Articles 8371 - 8400 of 11466

Full-Text Articles in Engineering

Bacterium-Like Particles As Delivery Vehicles For Multimeric Antigens, Kees Leenhouts May 2012

Bacterium-Like Particles As Delivery Vehicles For Multimeric Antigens, Kees Leenhouts

Vaccine Technology IV

No abstract provided.


Utilizing ‘Omics Tools To Investigate The Impact Of Process Changes On Product Quality In Cell Culture-Based Influenza Vaccine Production, E. Rapp, J. Rodig, J. Schwarzer, D. Hoeper, R. Hennig, Y. Genzel, U. Reichl May 2012

Utilizing ‘Omics Tools To Investigate The Impact Of Process Changes On Product Quality In Cell Culture-Based Influenza Vaccine Production, E. Rapp, J. Rodig, J. Schwarzer, D. Hoeper, R. Hennig, Y. Genzel, U. Reichl

Vaccine Technology IV

No abstract provided.


Suspension Vero Cells (Svero) For Poliovirus Production: Effect Of Culture Passage On Growth Kinetics And Productivity, Guillermina Forno May 2012

Suspension Vero Cells (Svero) For Poliovirus Production: Effect Of Culture Passage On Growth Kinetics And Productivity, Guillermina Forno

Vaccine Technology IV

No abstract provided.


Systematically Characterizing Adventitious Agent Tests For Biologics, Rebecca Sheets May 2012

Systematically Characterizing Adventitious Agent Tests For Biologics, Rebecca Sheets

Vaccine Technology IV

No abstract provided.


Automation And Multiplexing Of Immunoassays: Improving Precision And Throughput, Ilia Tikhonov May 2012

Automation And Multiplexing Of Immunoassays: Improving Precision And Throughput, Ilia Tikhonov

Vaccine Technology IV

No abstract provided.


Microbial Fermentation: New Tools To Speed-Up Vaccine Antigen Development And Increase Process Knowledge, Catherine Jourdat May 2012

Microbial Fermentation: New Tools To Speed-Up Vaccine Antigen Development And Increase Process Knowledge, Catherine Jourdat

Vaccine Technology IV

No abstract provided.


Building Pandemic Preparedness Through A Sustainable Enterprise For Influenza Vaccines, Robert Huebner May 2012

Building Pandemic Preparedness Through A Sustainable Enterprise For Influenza Vaccines, Robert Huebner

Vaccine Technology IV

No abstract provided.


High Cell Density Cultivations For Influenza Virus Production Using Suspension Cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, U. Reichl May 2012

High Cell Density Cultivations For Influenza Virus Production Using Suspension Cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, U. Reichl

Vaccine Technology IV

No abstract provided.


Rmce-Based Sf9 Cell Factory For Production Of Multi-Meric Vlps, Ana Teixera May 2012

Rmce-Based Sf9 Cell Factory For Production Of Multi-Meric Vlps, Ana Teixera

Vaccine Technology IV

No abstract provided.


Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg May 2012

Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg

Vaccine Technology IV

No abstract provided.


Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay May 2012

Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay

Vaccine Technology IV

No abstract provided.


Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai May 2012

Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai

Vaccine Technology IV

No abstract provided.


A Protein-Free Process And Product Protection System, Stephen Ward May 2012

A Protein-Free Process And Product Protection System, Stephen Ward

Vaccine Technology IV

No abstract provided.


Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity May 2012

Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity

Vaccine Technology IV

No abstract provided.


Oncolytic Viruses As Cancer Therapies, Stephen Rusell May 2012

Oncolytic Viruses As Cancer Therapies, Stephen Rusell

Vaccine Technology IV

No abstract provided.


Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca May 2012

Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca

Vaccine Technology IV

No abstract provided.


Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke May 2012

Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke

Vaccine Technology IV

No abstract provided.


A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters May 2012

A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters

Vaccine Technology IV

No abstract provided.


The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love May 2012

The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love

Vaccine Technology IV

No abstract provided.


High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu, Yap Chuan May 2012

High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu, Yap Chuan

Vaccine Technology IV

No abstract provided.


Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn May 2012

Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn

Vaccine Technology IV

No abstract provided.


Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz May 2012

Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz

Vaccine Technology IV

No abstract provided.


Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird May 2012

Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird

Vaccine Technology IV

No abstract provided.


Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid May 2012

Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid

Vaccine Technology IV

No abstract provided.


Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability, Sabrina Alejandra Gonzalez Blohm May 2012

Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability, Sabrina Alejandra Gonzalez Blohm

USF Tampa Graduate Theses and Dissertations

Stenosis is one of the most common causes for spinal surgery. Laminectomy decompression and fusion are surgical procedures prescribed for this condition. The intention of this work was to investigate the effects of a laminectomy decompression, followed by fusion, on a lumbar functional spinal unit (FSU) through in vitro dynamic (±8Nm at 0.125Hz) and quasi-static (±7.5Nm at 0.1Hz) biomechanical tests, for flexion, extension, bending and rotation motions.

Six FSUs where disarticulated from four human cadaveric lumbar spines (63 ± 12 years) and were tested under the following sequence: (1) intact, (2) laminectomy decompression, and (3) Pedicle Screw System (PSS), using …


Conference Program, Engineering Conferences International May 2012

Conference Program, Engineering Conferences International

Vaccine Technology IV

No abstract provided.


Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell May 2012

Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell

Vaccine Technology IV

No abstract provided.


Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson May 2012

Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson

Vaccine Technology IV

No abstract provided.


Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto May 2012

Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto

Vaccine Technology IV

No abstract provided.


Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach, Li Shi May 2012

Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach, Li Shi

Vaccine Technology IV

No abstract provided.